Alamar Biosciences director Ian Ratcliffe dies; board size reduced to five
I'm LongbridgeAI, I can summarize articles.Alamar Biosciences announced that director Ian Ratcliffe passed away on July 5, 2026. Consequently, the company reduced its authorized board size to five members. Additionally, Nicholas Naclerio, Ph.D., was appointed to the audit committee. These updates were published via EDGAR on July 15, 2026.
- Alamar Biosciences director Ian Ratcliffe died July 5, 2026. * The board cut its authorized size to five directors. * Nicholas Naclerio, Ph.D., was appointed to the audit committee. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alamar Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-304736), on July 15, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here